Visiting Professor Lecture Series continues April 17 with radiation oncology expert Dr. David Kirsch
The Taubman Institute's Visiting Professor Lecture series will continue April 17 with a presentation by David Kirsch M.D., Ph.D., associate professor of radiation oncology at Duke University Medical College.
Dr. Kirsch is a clinician-scientist whose laboratory at Duke studies the genesis and growth of cancer at the genetic level, with the aim of developing new therapies. He also is an expert in the the effects of radiation therapy.
He talk, entitled "Using Genetically Engineered Mouse Models to Study Radiation Biology," will take place on April 17 from 7:45 a.m. to 8:30 a.m. at the MCHC Auditorium at the University of Michigan's C.S. Mott Children's Hospital.
CME credit is available to physicians.
Visiting Professor lectures are generally held monthly and represent the Taubman Institute's ongoing committtment to furthering translational medical research by creating opportunities for the most talented physician-reserachers to exchange knowledge and ideas.
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New Emerging Scholar named
Scott Tomlins, M.D., an assistant profesor of pathology at U-M, has been designated the A. Alfred Taubman Emerging Scholar. Dr. Tomlins is an expert in prostate cancer research.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.